文献速递糖尿病性腺与生殖内分泌肥胖与代谢综合征

多囊卵巢综合征与妊娠期糖尿病妊娠结局的关联:DiGest 试验二次分析

Association between polycystic ovary syndrome and pregnancy outcomes in GDM: A secondary analysis of the DiGest trial.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究为 DiGest 双盲随机对照试验的二次分析,纳入 425 例 BMI≥25 kg/m² 的妊娠期糖尿病孕妇(50 例合并 PCOS,375 例不合并),比较减能饮食(1200 kcal/天)与标准能量饮食(2000 kcal/天)对母婴结局的影响。饮食干预效果在两组间无差异。

要点

  • 合并 PCOS 未增加 GDM 患者大多数不良妊娠结局风险,也未降低饮食干预疗效。
  • 在 BMI 与血糖可比的情况下,PCOS 对 GDM 妊娠结局的额外影响有限。

核心结论

  • 在 BMI 和血糖可比的 GDM 孕妇中,PCOS 与大多数不良妊娠结局风险增加无关,也未降低饮食干预的疗效。

研究设计与样本

  • DiGest 双盲随机对照试验的二次分析,纳入 8 个英国中心、BMI≥25 kg/m² 的 GDM 孕妇共 425 例(50 例合并 PCOS,375 例不合并)。
  • 干预为从入组(29 周)至分娩期间采用减能饮食(1200 kcal/天)或标准能量对照饮食(2000 kcal/天)。
  • PCOS 状态基于基线自报数据。

主要发现

  • 合并与不合并 PCOS 的 GDM 孕妇基线特征、血糖、BMI 及妊娠结局相似。
  • 两种饮食干预在合并与不合并 PCOS 的孕妇中结局相似。

关键数值与推荐

  • 减能饮食干预剂量:1200 kcal/天;标准能量对照饮食:2000 kcal/天。
  • 入组孕周:29 周;BMI 准入标准:≥25 kg/m²。

临床怎么用

  • 对 GDM 合并 PCOS 的孕妇,应关注新生儿黄疸的监测与管理。
  • PCOS 状态不应作为降低饮食干预力度的依据,减能饮食在该人群中同样适用。
  • 在 BMI 和血糖控制可比的前提下,PCOS 并非大多数不良妊娠结局的独立预测因素。

局限性

  • PCOS 状态为自报数据,可能存在错分偏倚。
  • 为二次分析,样本中 PCOS 例数较少(50 例),统计效能有限。
  • 研究人群限于 BMI≥25 kg/m² 的 GDM 孕妇,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Polycystic ovary syndrome (PCOS) is a risk factor for gestational diabetes mellitus (GDM) due to shared pathophysiological associations with insulin resistance and adiposity, and may increase the risk of suboptimal perinatal outcomes in GDM. It is unclear if this excess risk upon outcomes is attributable to PCOS, more severe hyperglycemia, higher maternal BMI or reduced efficacy of dietary interventions. OBJECTIVE: To assess associations of PCOS, dietary intervention and gestational weight loss with maternal and neonatal outcomes in women with GDM. METHODS/DESIGN: A secondary analysis from the DiGest double-blind randomized controlled trial. Data on self-reported PCOS status were collected at baseline. PARTICIPANTS: Pregnant women with GDM and BMI ≥25 kg/m2 from 8 UK centers (N = 425; 50 with PCOS and 375 without PCOS). INTERVENTION: Reduced-energy intervention diet (1200 kcal/day) or standard-energy control diet (2000 kcal/day) from enrollment (29 weeks) until delivery. MAIN OUTCOME MEASURES: Pregnancy outcomes, including maternal weight and continuous glucose metrics, physical and dietary data, and infant birthweight and jaundice, were compared between women with and without PCOS using univariate tests and multivariable regression models were applied for adjusted analysis. RESULTS: Women with GDM and PCOS had similar baseline characteristics, glycemia, BMI, and pregnancy outcomes compared with women with GDM alone, but their infants had higher rates of neonatal jaundice (24.4% vs 8.9%, P = .002). Outcomes across the dietary interventions were similar in women with and without PCOS. CONCLUSION: In women with GDM, PCOS was not associated with increased risks for most suboptimal pregnancy outcomes or reduced efficacy of a dietary intervention in this cohort where BMI and glycemia were comparable.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kusinski LC, Liu Z, Dib S, et al. Association between polycystic ovary syndrome and pregnancy outcomes in GDM: A secondary analysis of the DiGest trial. J Clin Endocrinol Metab. 2026. PMID: 41603372. doi:10.1210/clinem/dgag026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。